+91-8668442535
Home / Healthcare / Obstructiv

Obstructive sleep apnea (OSA) Market By Product (Polysomnography, Home Sleep Apnea Testing, Pulse Oximeter, Actigraphy Monitoring Device, Others) By End-user (Hospitals, Diagnostic Centers, Home Care Settings) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2028

The global Obstructive sleep apnea (OSA) Market report explores the critical analysis of the Obstructive sleep apnea (OSA) industry using key parameters. The report consists of investment strategies, the need for investments in the Obstructive sleep apnea (OSA) industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the Obstructive sleep apnea (OSA) industry, as well as how economic and non-economic barriers are helping the Obstructive sleep apnea (OSA) market grow. Moreover, the report analyzes the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. key technological developments, and other analyses such as porter's five forces analysis, PESTEL analysis, value chain analysis, etc.

obstructive-sleep-apnea-(osa)-market

Key Highlights of the report

How are the major segments performing in the Obstructive sleep apnea (OSA) Market?

In 2021, the Pulse Oximeter was the leading segment in the product. The oxygen saturation of the blood is frequently measured with pulse oximeters. They are used to continuously and non-invasively assess blood hemoglobin oxygen saturation throughout time. Their convenience has become a standard tool in hospitals and other healthcare facilities.

In 2021, the Home Care Settings in end-user was anticipated to experience considerable growth throughout the estimation period due to factors such as the rising acceptance of user-friendly homecare sleep apnea devices, increased awareness of home healthcare, etc. According to research papers from 2018 that were published, almost one-third of sleep apnea testing was done in home care settings.

Which region dominated the Obstructive sleep apnea (OSA) Market?

North America had the largest worldwide Obstructive Sleep Apnea (OSA) market in 2021. The high proportion in North America can be ascribed to the growing awareness of sleep apnea, its rising prevalence, and the widespread use of mouth appliances for the condition. According to data from the Sleep Foundation from 2021, snoring impacts 57% of males and 40% of women in the United States. More than 4,700 sleep labs are currently in operation in the United States, according to the Sleep Advisor Organization article 2021. As a result, over the past few years, the diagnosis and treatment of sleep problems have greatly increased in the U.S.

What is the obstructive sleep apnea (OSA) market's competitive environment?

The competitive environment of the obstructive sleep apnea (OSA) industry provides data on the total economic profit made by vendors and businesses, the sales and revenues generated in this industry, the global market share of obstructive sleep apnea (OSA), a summary of business organizations, the introduction of new products, and opportunities for the industrial obstructive sleep apnea (OSA) market. For instance, Oventus Medical and Aeroflow Healthcare entered into a collaboration agreement in June 2021 to offer Oventus' obstructive sleep apnea (OSA) treatment options, such as O2Vent Optima, directly to patients through sleep clinics in the U.S. On the other hand, Oventus Medical introduced 02Vent Optima in February 2021 as a CPAP therapy substitute in the U.S. through GoPAPfree. 02Vent Optima is a customizable oral appliance therapy device.

Executive Summary

What are all Opportunities in the Obstructive sleep apnea (OSA) Market?

The trend of patients turning to technologically advanced devices has tremendously facilitated the development of new treatments for sleep apnea. For instance, the use of oral devices like the mandibular advancement device (MAD) for OSA treatment has increased due to patient dissatisfaction with CPAP machines. Additionally, according to data released by NCBI based on numerous research conducted in different countries, it is thought that the compliance rate for CPAP machines among users has declined by up to 50.0%. Oral appliances, which have proven to be effective and offer comfort to patients throughout the treatment of the illness, were introduced to the market as alternatives as a result. The actometer is also well-liked by sleep clinics due to its non-invasiveness and reduced cost compared to standard polysomnography equipment. Due to escalating non-adherence to CPAP equipment and the expanding desire for cost-effective diagnostic tools, patients are increasingly resorting to mouth appliances and actometers to manage sleep apnea successfully.

Which are the major investments by the players in the Obstructive sleep apnea (OSA) Industry Market?

Due to its extraordinary adaptability and ability to be adjusted in every environment, obstructive sleep apnea (OSA) systems have been used in various sectors. Among the major players, a variety of investments are made; for example, Fisher & Paykel Healthcare and Counties Manukau Health (CM Health) have announced a $1.5 million cooperation agreement to support clinical research at Middlemore Hospital. Fisher & Paykel Healthcare will give the DHB up to $150,000 annually for research initiatives that benefit the South Auckland region's local communities for ten years.

Some of the major companies in the market are LivaNova, Koninklijke Philips N.V., SomnoMed, ResMed Inc., Medtronic, Resonea, Itamar Medical Ltd., Myerson, Fisher & Paykel Healthcare, Natus Medical Incorporated.

What are the Major Dynamics Factors for the Obstructive sleep apnea (OSA) Market?

The prevalence of obesity and hypertension is rising, along with the occurrences of sleep apnea, the senior population is growing, and the patient population in developing nations is becoming more conscious of the condition. Another main factor boosting the demand for sleep apnea devices is aging. The risk of acquiring this disorder is highest among the elderly. According to the World Population Prospects: 2017 report, there will be 962 million people 60 and older in the world in 2017, 2.1 billion in 2050, and 3.1 billion in 2100. The world's population of adults 60 and older is expanding more quickly than any other age group.

What are the Major Risks for the Obstructive sleep apnea (OSA) Market?

Patients with sleep apnea are burdened by the expensive costs of CPAP equipment, which are only partially covered by Medicare in the U.S., while being completely uninsured in other nations. Patients have a significant challenge due to the inconvenience, high cost of diagnosis and therapy, and the need for multiple medical appointments.

Which is the key Product Type in the Obstructive sleep apnea (OSA) Market?

The Pulse Oximeter sector dominated the Obstructive sleep apnea (OSA) market in 2021. The oxygen saturation of the blood is frequently measured with pulse oximeters. Pulse oximetry is used in many ways to evaluate and identify obstructive sleep apnea in adults and children. The patterns in the pulse oximetry data can be interpreted in the context of events in other physiological channels when pulse oximeters are utilized as a part of a nocturnal polysomnogram (PSG), potentially permitting extensive characterization of the pathophysiology. Over the projected period, the segment is also anticipated to grow as sleep apnea's prevalence increases globally. Globally, 425 million persons aged 30-69 have moderate to severe obstructive sleep apnoea (OSA), and 936 million adults aged 30-69 have mild to severe OSA, according to Adam V. Benjafield's article published in The Lancet Respiratory Medicine 2020.

Similarly, it's estimated that 50 to 60 percent of obese people and M.S. patients also have OSA. Thus, it is anticipated that the market will rise as sleep apnea becomes more common. A pulse oximeter made by Medtronic is known as the Nellcor portable SpO2 patient monitoring device, PM10N. This gadget is perfect for quick inspections and ongoing monitoring in different healthcare settings and at home. It is simple to use and operate because of its ergonomic shape and straightforward design. The availability of these kinds of devices will aid in expanding the market.

Additionally, many activities are going on right now that can help the market, such as product launches and approvals, partnerships, collaborations, mergers, and acquisitions. For instance, telehealth startup Tyto Care introduced its fingertip pulse oximeter (SpO2) in January 2021. This medical equipment allows users to remotely check their heart rate and blood oxygen saturation levels.

How is the Obstructive sleep apnea (OSA) Market performing in regions?

In 2021, the global Obstructive sleep apnea (OSA) market was dominated by North America. Due to the high prevalence of sleep-disordered breathing (SDB) and the growing elderly population in the area, the region is anticipated to grow both now and in the future. The United States controls the majority of the market in North America. For instance, the National Institute of Medicine reported in 2020 that the prevalence of OSA in the United States could reach 14% of men and 5% of women by that year. Populations of Hispanic, Black, and Asian descent have greater rates. In the U.S., there are about 25 million persons who suffer from obstructive sleep apnea. The most prevalent type of specific sleep disturbance is insomnia, which is reported by 10% of individuals with chronic insomnia and 30% of adults with short-term disorders. This fuels market expansion over the foreseeable future.

Lewis R. Kline, MD's study, published in UpToDate in January 2022, estimates that the prevalence in North America is between 10 and 15 percent for women and between 15 and 30 percent for males. Furthermore, a 10% rise in weight was associated with a six-fold increase in the risk of OSA, according to the same study. The adult obesity rate in the U.S. is 42.4%, according to the 2019 Behavioral Risk Factors Surveillance System (BFRSS) report from the Centers for Disease Control and Prevention. This is the first time the national average has surpassed 40% and provides additional evidence of the obesity problem in the nation. The market would be driven throughout the forecast period by the rising demand for sleep apnea due to the rising prevalence of obesity. According to a 2020 study by the American Sleep Association, 50 million to 70 million Americans will experience some form of sleep disorder. In addition, 5.4 million persons in Canada had sleep apnea diagnoses or were at an increased risk of developing OSA, according to a 2014 article in the Canadian Respiratory Journal.

What is the obstructive sleep apnea (OSA) market's regulatory landscape?

The regulatory landscape for this market is that governments are exploring a stricter regulatory approach across regions. For instance, Prescription oximeters are only accessible with a prescription and are subject to FDA scrutiny and 510(k) clearance. According to the FDA, these pulse oximeters must pass clinical testing to demonstrate their accuracy. Although they occasionally come with a prescription for home usage, hospitals and doctors' offices are where they are most frequently utilized.

What is the Market Size of Obstructive sleep apnea (OSA) regarding value?

In the future, it is predicted that the global market for obstructive sleep apnea (OSA) will expand at a sizable CAGR of XX%. The global market for obstructive sleep apnea (OSA) was projected to be worth USD XX million in 2021 and USD XX million in 2028.

What are major players planning for the future of the Obstructive sleep apnea (OSA) Market?

The major participants in the market for sleep apnea devices are focused on obtaining regulatory approvals, releasing cutting-edge technologies, and entering into merger and partnership arrangements with other businesses. The market for sleep apnea equipment is projected to expand due to these tactics. BiPAP (Bilevel Positive Airway Pressure) machines, typically used to treat sleep apnea or COPD, are being converted into ventilators using innovative 3D printed parts as part of business expansion strategies adopted by firms operating in the global sleep apnea devices market.

Segmentation of Global Obstructive sleep apnea (OSA) Market-

Global Obstructive sleep apnea (OSA) Market – By Product

  • Polysomnography
  • Home Sleep Apnea Testing
  • Pulse Oximeter
  • Actigraphy Monitoring Device
  • Others

Global Obstructive sleep apnea (OSA) Market – By End-user

  • Hospitals
  • Diagnostic Centers
  • Home Care Settings

Global Obstructive sleep apnea (OSA) Market – By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific

Frequently asked questions about the Obstructive sleep apnea (OSA)

Due to the temporary closure of sleep clinics and medical equipment suppliers due to quarantines and government limitations, diagnostic device suppliers saw a reduction in sales revenue growth of sleep apnea diagnostic devices.

North America held the largest market share for Obstructive sleep apnea (OSA).

Obesity and hypertension are becoming more common, along with sleep apnea cases, the elderly population is expanding, and patients in emerging countries are becoming more aware of their illness.

Pulse Oximeter segment had a major share in 2021.

The home Care Settings segment had a major share in the global market in 2021.

Obstructive sleep apnea (OSA) Market Scope

Report Attribute Details
Market Value in 2021 USD XX million
Market Value in 2028 USD XX million
CAGR XX%
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Trusted By
Godaddy
Published Date:  Sep 2022
Category:  Healthcare
Report ID:   60665
Report Format:   PDF
Pages:   120
Rating:    4.2 (30)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support